Keith Horspool, PhDVice President Pharmaceutics at Boehringer Ingelheim
Keith is Vice President of External Alternative CMC Development (EACD) at BI. EACD operates as a “biotech within pharma” using an integrated network of virtual resources to deliver all CMC requirements for projects, applying alternative development approaches for NCEs and NCE‐like new modalities. Prior to joining BI, Keith worked at Pfizer and AstraZeneca. He has worked in Pharma for more than 30 years with experience managing preformulation, product development, drug delivery and materials science. Keith has diverse experience with a broad range of delivery systems and various routes of delivery, particularly oral, inhalation and parenteral delivery.